147 related articles for article (PubMed ID: 218426)
1. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
[TBL] [Abstract][Full Text] [Related]
2. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
[TBL] [Abstract][Full Text] [Related]
3. The glucagonoma syndrome.
Shupack JL; Berczeller PH; Stevens DM
J Dermatol Surg Oncol; 1978 Mar; 4(3):242-7. PubMed ID: 204668
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
[TBL] [Abstract][Full Text] [Related]
5. Glucagonoma syndrome. Report of two cases and literature review.
Binnick AN; Spencer SK; Dennison WL; Horton ES
Arch Dermatol; 1977 Jun; 113(6):749-54. PubMed ID: 194536
[TBL] [Abstract][Full Text] [Related]
6. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
[TBL] [Abstract][Full Text] [Related]
7. Insulin and somatostatin releasing islet cell tumor caused hypoglycemia.
Karasawa Y; Mochizuki T; Kawa S; Aoki Y; Ueno T; Watanabe T; Kawasaki S; Miyagawa S; Itoh N; Tamai C; Sakurai A; Kiyosawa K
Intern Med; 2001 Apr; 40(4):324-30. PubMed ID: 11334393
[TBL] [Abstract][Full Text] [Related]
8. A familial glucagonoma syndrome: genetic, clinical and biochemical features.
Stacpoole PW; Jaspan J; Kasselberg AG; Halter SA; Polonsky K; Gluck FW; Liljenquist JE; Rabin D
Am J Med; 1981 May; 70(5):1017-26. PubMed ID: 6112877
[TBL] [Abstract][Full Text] [Related]
9. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
[TBL] [Abstract][Full Text] [Related]
10. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
Elsborg L; Glenthøj A
Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
[TBL] [Abstract][Full Text] [Related]
11. The glucagonoma syndrome: surgically curable diabetes.
Higgins GA; Recant L; Fischman AB
Am J Surg; 1979 Jan; 137(1):142-8. PubMed ID: 215044
[No Abstract] [Full Text] [Related]
12. A malignant insulinoma transformed into a glucagonoma syndrome.
Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
[No Abstract] [Full Text] [Related]
13. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
[TBL] [Abstract][Full Text] [Related]
14. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
15. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.
Valverde I; Lemon HM; Kessinger A; Unger RH
J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682
[TBL] [Abstract][Full Text] [Related]
16. Pattern of immunoreactive glucagon in portal, arterial and peripheral plasma before and after removal of glucagonoma.
Villar HV; Johnson DG; Lynch PJ; Pond GD; Smith PH
Am J Surg; 1981 Jan; 141(1):148-52. PubMed ID: 6257127
[TBL] [Abstract][Full Text] [Related]
17. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
[TBL] [Abstract][Full Text] [Related]
18. Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome.
Kahan RS; Perez-Figaredo RA; Neimanis A
Arch Dermatol; 1977 Jun; 113(6):792-7. PubMed ID: 194537
[TBL] [Abstract][Full Text] [Related]
19. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
Hendriks T; Jansen JB; van Tongeren JH
Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
[TBL] [Abstract][Full Text] [Related]
20. Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma.
Katz R; Fischmann AB; Galotto J; Guccio JG; Higgins GA; Ortega LG; West WH; Recant L
Cancer; 1979 Aug; 44(2):558-63. PubMed ID: 476569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
